Clario

Clario is a global provider of endpoint technology services and solutions for clinical trial management. With over 50 years of experience, the company has supported more than 30,000 clinical trials in over 100 countries, contributing to over 700 FDA and EMA new drug approvals. Clario specializes in integrating scientific expertise, advanced technology, and operational scale to generate high-quality clinical evidence for pharmaceutical, biotechnology, and medical device companies. The company offers a comprehensive endpoint technology platform that includes software, devices, and AI solutions. Its services cover all trial phases and span over 20 therapeutic areas, such as neurology, oncology, and cardiovascular health. Clario's key solutions include medical imaging, cardiac safety monitoring, respiratory data collection, and electronic clinical outcome assessments. The company emphasizes patient diversity and health equity in its trial designs and maintains a commitment to corporate social responsibility.